Advertisement
Advertise here Publish your press releases here Sponsor BioPortfolio
Follow us on Twitter Sign up for daily news and research emails Contributors wanted

The Society of Memorial Sloan-Kettering Cancer Center Company Profile

09:12 EDT 24th April 2014 | BioPortfolio


News Articles [5586 Associated News Articles listed on BioPortfolio]

Study reveals mechanisms cancer cells use to establish metastatic brain tumors

(Memorial Sloan-Kettering Cancer Center) New research from Memorial Sloan Kettering provides fresh insight into the biologic mechanisms that individual cancer cells use to metastasize to the brain.

Memorial Sloan-Kettering to use Sutro's technology for new bispecific antibodies

US-based biopharmaceutical firm Sutro Biopharma has entered into a collaboration agreement with Memorial Sloan-Kettering Cancer Center to produce bispecific antibodies for the treatment of neuroblasto...

Fred Hutchinson, Memorial Sloan-Kettering team up to launch Juno Therapeutics

The Fred Hutchinson Cancer Research Center (Fred Hutch) and Memorial Sloan-Kettering Cancer Center (MSKCC), along with pediatric partner Seattle Children’s Research Institute, have joined forces to...

Novartis gets rights to ESKs from Eureka, Memorial Sloan-Kettering

Eureka Therapeutics Inc. (mAbs) and Memorial Sloan-Kettering Cancer Center (MSKCC) granted Novartis AG exclusive global rights to develop ESK antibodies for all indications.

Memorial Sloan-Kettering to use Sutro's cell-free protein synthesis technology to produce bispecific antibodies

Sutro Biopharma, a biopharmaceutical company developing a new generation of protein therapeutics, including next-generation antibody drug conjugates and bispecific antibodies, today announced that it...

Memorial Sloan-Kettering Cancer Center receives $90M in new financial support from Ludwig

Memorial Sloan-Kettering Cancer Center, along with five other elite academic institutions, will share an unprecedented total of $540 million in new financial support from Ludwig Cancer Research, on be...

Memorial Sloan-Kettering study reveals mechanisms cancer cells use to establish metastatic brain tumors

New research from Memorial Sloan-Kettering provides fresh insight into the biologic mechanisms that individual cancer cells use to metastasize to the brain.

GlaxoSmithKline, Gustave Roussy, Memorial Sloan-Kettering Cancer Center, Netherlands Cancer Institute, Princess Margaret Cancer Center, University of Texas MD Anderson Cancer Center, Vall d'Hebron Institute of Oncology cancer news

PubMed Articles [7354 Associated PubMed Articles listed on BioPortfolio]

Local Relapse After Breast-Conserving Therapy for Ductal Carcinoma In Situ: A European Single-Center Experience and External Validation of the Memorial Sloan-Kettering Cancer Center DCIS Nomogram.

Adjuvant treatments after breast-conserving surgery (BCS) for ductal carcinoma in situ to prevent local relapse are considered standard of care. However, patient selection to prevent increased morbidi...

Natural history of small radioiodine-avid bone metastases that have no structural correlate on imaging studies.

Bone metastases from differentiated thyroid cancer are generally resistant to radioiodine (RAI) therapy and are associated with poor prognosis. However, in a recent study from our group we noted a sma...

Report of patients with chronic myeloid leukemia Kidwai Memorial Institute of Oncology, Bangalore over 15 years.

Kidwai Memorial Institute of Bangalore is one of the most comprehensive and major regional cancer center. It was established in 1974 and caters population not only from Karnataka, but also from Tamil...

Dose distribution homogeneity in two TBI techniques-Analysis of 208 irradiated patients conducted in Stanislaw Leszczynski Memorial Hospital, Katowice.

To analyze and compare dose distribution homogeneity in selected points (especially in the chest wall region) for patients irradiated with two different TBI techniques to achieve a uniform total dose...

Palliative care among elderly cancer patients: Own experience.

Annually, more than 27,000 persons die of cancer in the Czech Republic. It is known that in addition to the demographic aging of the Czech population, the cancer burden is increased.

Clinical Trials [3089 Associated Clinical Trials listed on BioPortfolio]

Measurement of Cancer-Related Risk Perception in Smokers

The purpose of this study is to develop an accurate way of measuring people's thoughts about cancer risk. The researchers at the Queens Hospital Center, Memorial Sloan-Kettering Cancer Cen...

Acute Normovolemic Hemodilution Versus Standard Intraoperative Management in Patients Having Hepatic Resection and Pancreaticoduodenectomy

With a major liver or pancreas operation, there is a chance that one will require a transfusion of blood products (either red blood cells or plasma). This may be necessary during the oper...

Collection of Tissue, Blood, and Cells to Be Used For Studying the Causes, Prevention, Diagnosis, and Treatment of Breast Cancer

The purpose of this study is to collect a blood sample from patients with breast disease (cases) and from individuals without breast cancer (controls)that may be used for research purposes...

Behavioral Intervention For BMT/SCT Survivors

The purpose of this study is to understand how to help survivors of bone marrow transplant and stem cell transplant (BMT/SCT) with emotional distress. BMT/SCT has become a more common type...

Acupuncture For Pancreatic Cancer Pain

Pain is a common problem in patients with pancreatic cancer. Some patients suffer from pain despite medication. We, the researchers at Memorial Sloan-Kettering Cancer Center, are conductin...

Companies [2973 Associated Companies listed on BioPortfolio]

Memorial Sloan-Kettering Cancer Center

Memorial Sloan-Kettering Cancer Center's tradition of care began more than 100 years ago. In 1884, the cornerstone of the New York Cancer Hospital -- what was later to become Memorial Hospital for Can...

The Society of Memorial Sloan-Kettering Cancer Center

Optimer Pharmaceuticals

Optimer's core competence includes the development of innovative drugs for treating diseases that currently have no satisfactory therapy. These include antibiotics for drug-resistant bacterial infecti...

Mojave Therapeutics Incorporated

Mojave Therapeutics is building a new class of biopharmaceuticals that primes the immune system to fight cancer and viral diseases. Mojave’s core technologies, developed by leading researchers at Me...

MoleSafe USA

MoleSafe USA is the world's most advanced melanoma screening program designed to protect you and your family from the deadly effects of melanoma skin cancer. MoleSafe is a state-of-the-art procedu...

More Information about "The Society of Memorial Sloan-Kettering Cancer Center" on BioPortfolio

We have published hundreds of The Society of Memorial Sloan-Kettering Cancer Center news stories on BioPortfolio along with dozens of The Society of Memorial Sloan-Kettering Cancer Center Clinical Trials and PubMed Articles about The Society of Memorial Sloan-Kettering Cancer Center for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of The Society of Memorial Sloan-Kettering Cancer Center Companies in our database. You can also find out about relevant The Society of Memorial Sloan-Kettering Cancer Center Drugs and Medications on this site too.

Search BioPortfolio:
Advertisement

Corporate Database Quicklinks



Searches Linking to this Company Record

Advertisement